We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evolving treatment strategies in CML – moving from early and deep molecular responses to TKI discontinuation and treatment‐free remission: is there a need for longer‐term trial outcomes?
- Authors
Eşkazan, Ahmet Emre
- Abstract
An editorial is presented on the developments in the treatment of chronic myeloid leukaemia (CML) with the introduction of BCR-ABL1 tyrosine kinase inhibitors (TKIs). It expresses the view that CML is a highly controllable disease with the availability of TKIs, and treatment-free remission is a new therapeutic goal for the eligible patients.
- Subjects
TREATMENT of chronic myeloid leukemia; DISEASE remission; DRUG efficacy; DRUG development
- Publication
British Journal of Clinical Pharmacology, 2018, Vol 84, Issue 8, p1635
- ISSN
0306-5251
- Publication type
Editorial
- DOI
10.1111/bcp.13637